Logo image of ASAN

ASANA INC - CL A (ASAN) Stock Fundamental Analysis

NYSE:ASAN - New York Stock Exchange, Inc. - US04342Y1047 - Common Stock - Currency: USD

14.295  +0.41 (+2.99%)

Fundamental Rating

3

Taking everything into account, ASAN scores 3 out of 10 in our fundamental rating. ASAN was compared to 282 industry peers in the Software industry. ASAN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASAN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ASAN has reported negative net income.
In the past year ASAN had a positive cash flow from operations.
In the past 5 years ASAN always reported negative net income.
ASAN had negative operating cash flow in 4 of the past 5 years.
ASAN Yearly Net Income VS EBIT VS OCF VS FCFASAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of ASAN (-26.43%) is worse than 71.28% of its industry peers.
With a Return On Equity value of -98.11%, ASAN is not doing good in the industry: 76.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -26.43%
ROE -98.11%
ROIC N/A
ROA(3y)-32.7%
ROA(5y)-33.56%
ROE(3y)-101.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASAN Yearly ROA, ROE, ROICASAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 89.36%, ASAN belongs to the top of the industry, outperforming 97.16% of the companies in the same industry.
ASAN's Gross Margin has been stable in the last couple of years.
ASAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y0.75%
ASAN Yearly Profit, Operating, Gross MarginsASAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

4

2. Health

2.1 Basic Checks

ASAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASAN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ASAN has more shares outstanding
ASAN has a better debt/assets ratio than last year.
ASAN Yearly Shares OutstandingASAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ASAN Yearly Total Debt VS Total AssetsASAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

ASAN has an Altman-Z score of 0.23. This is a bad value and indicates that ASAN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.23, ASAN is not doing good in the industry: 69.86% of the companies in the same industry are doing better.
The Debt to FCF ratio of ASAN is 3.49, which is a good value as it means it would take ASAN, 3.49 years of fcf income to pay off all of its debts.
ASAN's Debt to FCF ratio of 3.49 is fine compared to the rest of the industry. ASAN outperforms 63.12% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that ASAN is not too dependend on debt financing.
ASAN has a Debt to Equity ratio (0.16) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.49
Altman-Z 0.23
ROIC/WACCN/A
WACC10.85%
ASAN Yearly LT Debt VS Equity VS FCFASAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.47 indicates that ASAN should not have too much problems paying its short term obligations.
ASAN's Current ratio of 1.47 is in line compared to the rest of the industry. ASAN outperforms 47.87% of its industry peers.
ASAN has a Quick Ratio of 1.47. This is a normal value and indicates that ASAN is financially healthy and should not expect problems in meeting its short term obligations.
ASAN's Quick ratio of 1.47 is in line compared to the rest of the industry. ASAN outperforms 47.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
ASAN Yearly Current Assets VS Current LiabilitesASAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.89% over the past year.
The Revenue has grown by 9.83% in the past year. This is quite good.
Measured over the past years, ASAN shows a very strong growth in Revenue. The Revenue has been growing by 38.39% on average per year.
EPS 1Y (TTM)88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
Revenue 1Y (TTM)9.83%
Revenue growth 3Y24.14%
Revenue growth 5Y38.39%
Sales Q2Q%8.59%

3.2 Future

ASAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.73% yearly.
The Revenue is expected to grow by 9.89% on average over the next years. This is quite good.
EPS Next Y277.83%
EPS Next 2Y116.05%
EPS Next 3Y78.22%
EPS Next 5Y42.73%
Revenue Next Year8.13%
Revenue Next 2Y8.56%
Revenue Next 3Y9.09%
Revenue Next 5Y9.89%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ASAN Yearly Revenue VS EstimatesASAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ASAN Yearly EPS VS EstimatesASAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASAN. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 41.22, the valuation of ASAN can be described as expensive.
ASAN's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, ASAN is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 41.22
ASAN Price Earnings VS Forward Price EarningsASAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

ASAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 308.25
EV/EBITDA N/A
ASAN Per share dataASAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ASAN's earnings are expected to grow with 78.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y116.05%
EPS Next 3Y78.22%

0

5. Dividend

5.1 Amount

ASAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASANA INC - CL A

NYSE:ASAN (7/14/2025, 12:17:09 PM)

14.295

+0.41 (+2.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)09-01 2025-09-01/amc
Inst Owners45.47%
Inst Owner Change0%
Ins Owners39.29%
Ins Owner Change4.94%
Market Cap3.36B
Analysts56.36
Price Target16.8 (17.52%)
Short Float %9.67%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.19%
Min EPS beat(2)100%
Max EPS beat(2)154.38%
EPS beat(4)4
Avg EPS beat(4)91.3%
Min EPS beat(4)39.8%
Max EPS beat(4)154.38%
EPS beat(8)8
Avg EPS beat(8)72.8%
EPS beat(12)12
Avg EPS beat(12)59.39%
EPS beat(16)16
Avg EPS beat(16)48.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-1.03%
Revenue beat(4)0
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)-0.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)0.05%
Revenue beat(16)9
Avg Revenue beat(16)1.19%
PT rev (1m)3.41%
PT rev (3m)1.45%
EPS NQ rev (1m)2.56%
EPS NQ rev (3m)19.11%
EPS NY rev (1m)19.52%
EPS NY rev (3m)16.82%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 41.22
P/S 4.55
P/FCF 308.25
P/OCF 142.62
P/B 14.24
P/tB 14.24
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.35
Fwd EY2.43%
FCF(TTM)0.05
FCFY0.32%
OCF(TTM)0.1
OCFY0.7%
SpS3.14
BVpS1
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.43%
ROE -98.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.36%
FCFM 1.48%
ROA(3y)-32.7%
ROA(5y)-33.56%
ROE(3y)-101.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y0.75%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.49
Debt/EBITDA N/A
Cap/Depr 68.54%
Cap/Sales 1.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z 0.23
F-Score5
WACC10.85%
ROIC/WACCN/A
Cap/Depr(3y)72.76%
Cap/Depr(5y)478.8%
Cap/Sales(3y)1.67%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
EPS Next Y277.83%
EPS Next 2Y116.05%
EPS Next 3Y78.22%
EPS Next 5Y42.73%
Revenue 1Y (TTM)9.83%
Revenue growth 3Y24.14%
Revenue growth 5Y38.39%
Sales Q2Q%8.59%
Revenue Next Year8.13%
Revenue Next 2Y8.56%
Revenue Next 3Y9.09%
Revenue Next 5Y9.89%
EBIT growth 1Y9.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year226.6%
EBIT Next 3Y67.9%
EBIT Next 5Y40.69%
FCF growth 1Y107.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.67%
OCF growth 3YN/A
OCF growth 5YN/A